Crossmark

Effect of HCV treatment with DAAs on serum intestinal fatty acid binding protein (I-FABP) as a marker of intestinal permeability in HCV/HIV co-infected patients

Crossref DOI link: https://doi.org/10.1186/s43066-023-00255-x

Published Online: 2023-04-29

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Abdelhaleem, Hanan

Khairy, Marwa

Abdo, Mahmoud

Cordie, Ahmed

Elsharkawy, Marwa

Alem, Shereen Abdel

Elsharkawy, Aisha

Al sehemy, Lamiaa https://orcid.org/0000-0003-3101-9233
Esmat, Gamal
Funding

Funding for this research was provided by:

Cairo University (university (N-149-2018))
License Information

Text and Data Mining valid from 2023-04-29

Version of Record valid from 2023-04-29
More Information

Article History

Received: 27 January 2023

Accepted: 12 April 2023

First Online: 29 April 2023

Declarations

:

: The approval of the Institutional Review Board (IRB) of Kasr Alainy School of Medicine, Cairo University, was obtained for study conduction and publication (D-43–2019) under the umbrella project entitled “HCV prevalence among patients infected with HIV registered for HAART in Imbaba fever hospital in Cairo” approved by Cairo University (N-149–2018).

: Is not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below